Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
SGA星耀联盟 (STAR GALAXY ALLY) was founded in 2024 and positions itself as an Asian pharmaceutical resources enterprise alliance, with members in Singapore, Shanghai, and Taipei. Based on the website copy, it is not a SaaS product or enterprise software in the conventional sense. Instead, it is an integrated service organization for pharmaceutical, health supplement, and medical device companies, offering regulatory registration consulting, Southeast Asia market access support, and pharmaceutical cold-chain logistics.
Its core services are built around the pharmaceutical value chain. First, it helps clients apply for drug registration certificates and medical device permits in Singapore and major Southeast Asian countries, while also providing regulatory consulting. Second, it offers GDP-compliant temperature-controlled supply chain services, including transportation for sensitive medicines, vaccines, clinical trials, laboratory reagents, supplies, and equipment. Third, it provides temperature-controlled packaging materials, Door-to-Door Delivery, route validation, qualification and compliance consulting, and related services. The website also mentions CMO/CSO consulting, market sales channel development, and end-to-end supply chain planning, making it suitable for pharmaceutical companies that need support from registration through to logistics execution.
The website does not disclose packages, standard pricing, payment methods, free trials, or subscription models. It also does not indicate the availability of a cloud-based system, self-hosted software, APIs, third-party integrations, permission management, or team collaboration features. Therefore, if evaluated from a SaaS perspective, the available information is clearly insufficient. It should be viewed more as project-based consulting and logistics services rather than a software product that can be purchased directly.
Its strengths lie in its specialized service scenarios, with a focus on pharmaceutical registration and cold-chain logistics, while emphasizing GDP standards, quality validation, and temperature control. In terms of the team, the website mentions that its Asia-Pacific regulatory lead has years of experience in drug registration and multinational regulatory affairs. The limitations are that the website does not provide measurable service pricing, delivery timelines, service SLAs, system platform capabilities, or customer self-service tool information, so further communication and confirmation are needed before procurement.
It is better suited for pharmaceutical companies, biotech firms, and medical device companies planning to enter markets such as Singapore, Malaysia, Vietnam, Indonesia, and Thailand, as well as organizations requiring cross-border temperature-controlled transport for clinical samples, vaccines, or sensitive medicines. Access from China cannot be determined from the website copy, and payment methods are not specified. If users are actually looking for a SaaS alternative, they should consider pharmaceutical registration management systems, cold-chain TMS/WMS, QMS, or pharmaceutical compliance management software.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on sga.one official site.
sga.one is an Singapore SaaS provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach sga.one directly.